Skip to main content
PMC home page
Biochemical Journal logoLink to Biochemical Journal
. 1996 Oct 15;319(Pt 2):399–405. doi: 10.1042/bj3190399

Protein C activation on endothelial cells by prothrombin activation products generated in situ: meizothrombin is a better protein C activator than alpha-thrombin.

T M Hackeng 1, G Tans 1, S J Koppelman 1, P G de Groot 1, J Rosing 1, B N Bouma 1
PMCID: PMC1217782  PMID: 8912673

Abstract

The conversion of protein C into activated protein C (APC) by the thrombin-thrombomodulin complex on the surface of endothelial cells initiates an essential negative feedback reaction on blood coagulation. APC, together with its non-enzymic cofactor protein S, inactivates factors Va and VIIIa, the non-enzymic protein cofactors of the prothrombinase and intrinsic tenase complex, by proteolytic degradation. In this study we report that prothrombin activation products, generated by the prothrombinase complex on the surface of quiescent endothelial cells, are able to activate protein C. Subsequent inactivation of factor Va by the APC that was formed decreased the rate of prothrombin activation, thus demonstrating in vitro the negative feedback loop on coagulation factor activation. The anticoagulant feedback reaction of APC on the prothrombinase complex was stimulated 3-4-fold by the addition of protein S but not by thrombin-cleaved protein S or by protein S complexed with C4b-binding protein. Stimulation of endothelial cells with 50 pM tumour necrosis factor (TNF) or 500 pM interleukin 1 (IL-1) resulted in a 70% decrease in activation of protein C by exogenously added alpha-thrombin, which seemed to be due to down-regulation of thrombomodulin activity on the surface of endothelial cells. However, when prothrombin activation products generated in situ were allowed to activate protein C, stimulation of endothelial cells with TNF and IL-1 resulted in only a 25% decrease in activation of protein C. Stimulation with TNF or IL-1 did not affect the ability of endothelial cells to support prothrombinase activity. We investigated whether the differences in extent of protein C activation by exogenously added alpha-thrombin and by prothrombin activation products generated in situ were due to meizothrombin formed during prothrombin activation. Previous reports from our groups revealed that meizothrombin is generated as a transient intermediate during prothrombin activation on phospholipid vesicles and endothelial cells. Here we show that meizothrombin is at least a 6-fold better activator of protein C on the surface of endothelial cells than is alpha-thrombin. These results demonstrate that meizothrombin, formed during the initial phase of prothrombin activation, efficiently down-regulates both its own formation and that of thrombin.

Full Text

The Full Text of this article is available as a PDF (457.8 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bakker H. M., Tans G., Janssen-Claessen T., Thomassen M. C., Hemker H. C., Griffin J. H., Rosing J. The effect of phospholipids, calcium ions and protein S on rate constants of human factor Va inactivation by activated human protein C. Eur J Biochem. 1992 Aug 15;208(1):171–178. doi: 10.1111/j.1432-1033.1992.tb17171.x. [DOI] [PubMed] [Google Scholar]
  2. Coalson J. J., Benjamin B., Archer L. T., Beller B., Gilliam C. L., Taylor F. B., Hinshaw L. B. Prolonged shock in the baboon subjected to infusion of E. coli endotoxin. Circ Shock. 1978;5(4):423–437. [PubMed] [Google Scholar]
  3. Comp P. C., Esmon C. T. Activated protein C inhibits platelet prothrombin-converting activity. Blood. 1979 Dec;54(6):1272–1281. [PubMed] [Google Scholar]
  4. Conway E. M., Rosenberg R. D. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells. Mol Cell Biol. 1988 Dec;8(12):5588–5592. doi: 10.1128/mcb.8.12.5588. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Dahlbäck B., Stenflo J. Inhibitory effect of activated protein C on activation of prothrombin by platelet-bound factor Xa. Eur J Biochem. 1980 Jun;107(2):331–335. doi: 10.1111/j.1432-1033.1980.tb06033.x. [DOI] [PubMed] [Google Scholar]
  6. Doyle M. F., Mann K. G. Multiple active forms of thrombin. IV. Relative activities of meizothrombins. J Biol Chem. 1990 Jun 25;265(18):10693–10701. [PubMed] [Google Scholar]
  7. Eaton D., Rodriguez H., Vehar G. A. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity. Biochemistry. 1986 Jan 28;25(2):505–512. doi: 10.1021/bi00350a035. [DOI] [PubMed] [Google Scholar]
  8. Esmon C. T. Molecular events that control the protein C anticoagulant pathway. Thromb Haemost. 1993 Jul 1;70(1):29–35. [PubMed] [Google Scholar]
  9. Esmon C. T., Taylor F. B., Jr, Snow T. R. Inflammation and coagulation: linked processes potentially regulated through a common pathway mediated by protein C. Thromb Haemost. 1991 Jul 12;66(1):160–165. [PubMed] [Google Scholar]
  10. Fay P. J., Smudzin T. M., Walker F. J. Activated protein C-catalyzed inactivation of human factor VIII and factor VIIIa. Identification of cleavage sites and correlation of proteolysis with cofactor activity. J Biol Chem. 1991 Oct 25;266(30):20139–20145. [PubMed] [Google Scholar]
  11. Fukudome K., Esmon C. T. Identification, cloning, and regulation of a novel endothelial cell protein C/activated protein C receptor. J Biol Chem. 1994 Oct 21;269(42):26486–26491. [PubMed] [Google Scholar]
  12. Fulcher C. A., Gardiner J. E., Griffin J. H., Zimmerman T. S. Proteolytic inactivation of human factor VIII procoagulant protein by activated human protein C and its analogy with factor V. Blood. 1984 Feb;63(2):486–489. [PubMed] [Google Scholar]
  13. Gladson C. L., Scharrer I., Hach V., Beck K. H., Griffin J. H. The frequency of type I heterozygous protein S and protein C deficiency in 141 unrelated young patients with venous thrombosis. Thromb Haemost. 1988 Feb 25;59(1):18–22. [PubMed] [Google Scholar]
  14. Hackeng T. M., Hessing M., van 't Veer C., Meijer-Huizinga F., Meijers J. C., de Groot P. G., van Mourik J. A., Bouma B. N. Protein S binding to human endothelial cells is required for expression of cofactor activity for activated protein C. J Biol Chem. 1993 Feb 25;268(6):3993–4000. [PubMed] [Google Scholar]
  15. Hackeng T. M., van 't Veer C., Meijers J. C., Bouma B. N. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa. J Biol Chem. 1994 Aug 19;269(33):21051–21058. [PubMed] [Google Scholar]
  16. Haley P. E., Doyle M. F., Mann K. G. The activation of bovine protein C by factor Xa. J Biol Chem. 1989 Sep 25;264(27):16303–16310. [PubMed] [Google Scholar]
  17. Heeb M. J., Mesters R. M., Tans G., Rosing J., Griffin J. H. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C. J Biol Chem. 1993 Feb 5;268(4):2872–2877. [PubMed] [Google Scholar]
  18. Heeb M. J., Rosing J., Bakker H. M., Fernandez J. A., Tans G., Griffin J. H. Protein S binds to and inhibits factor Xa. Proc Natl Acad Sci U S A. 1994 Mar 29;91(7):2728–2732. doi: 10.1073/pnas.91.7.2728. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hessing M., Kanters D., Hackeng T. M., Bouma B. N. Identification of different forms of human C4b-binding protein lacking beta-chain and protein S binding ability. Thromb Haemost. 1990 Oct 22;64(2):245–250. [PubMed] [Google Scholar]
  20. Hirokawa K., Aoki N. Up-regulation of thrombomodulin in human umbilical vein endothelial cells in vitro. J Biochem. 1990 Nov;108(5):839–845. doi: 10.1093/oxfordjournals.jbchem.a123290. [DOI] [PubMed] [Google Scholar]
  21. Jaffe E. A., Nachman R. L., Becker C. G., Minick C. R. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest. 1973 Nov;52(11):2745–2756. doi: 10.1172/JCI107470. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Kalafatis M., Bertina R. M., Rand M. D., Mann K. G. Characterization of the molecular defect in factor VR506Q. J Biol Chem. 1995 Feb 24;270(8):4053–4057. doi: 10.1074/jbc.270.8.4053. [DOI] [PubMed] [Google Scholar]
  23. Kalafatis M., Rand M. D., Mann K. G. The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem. 1994 Dec 16;269(50):31869–31880. [PubMed] [Google Scholar]
  24. Kane W. H., Majerus P. W. Purification and characterization of human coagulation factor V. J Biol Chem. 1981 Jan 25;256(2):1002–1007. [PubMed] [Google Scholar]
  25. Kapiotis S., Besemer J., Bevec D., Valent P., Bettelheim P., Lechner K., Speiser W. Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells. Blood. 1991 Jul 15;78(2):410–415. [PubMed] [Google Scholar]
  26. Kisiel W., Canfield W. M., Ericsson L. H., Davie E. W. Anticoagulant properties of bovine plasma protein C following activation by thrombin. Biochemistry. 1977 Dec 27;16(26):5824–5831. doi: 10.1021/bi00645a029. [DOI] [PubMed] [Google Scholar]
  27. Kisiel W. Human plasma protein C: isolation, characterization, and mechanism of activation by alpha-thrombin. J Clin Invest. 1979 Sep;64(3):761–769. doi: 10.1172/JCI109521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Koedam J. A., Meijers J. C., Sixma J. J., Bouma B. N. Inactivation of human factor VIII by activated protein C. Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest. 1988 Oct;82(4):1236–1243. doi: 10.1172/JCI113721. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Marlar R. A., Kleiss A. J., Griffin J. H. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood. 1982 May;59(5):1067–1072. [PubMed] [Google Scholar]
  30. Moore K. L., Andreoli S. P., Esmon N. L., Esmon C. T., Bang N. U. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro. J Clin Invest. 1987 Jan;79(1):124–130. doi: 10.1172/JCI112772. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Moore K. L., Esmon C. T., Esmon N. L. Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. Blood. 1989 Jan;73(1):159–165. [PubMed] [Google Scholar]
  32. Nawroth P. P., Handley D. A., Esmon C. T., Stern D. M. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. Proc Natl Acad Sci U S A. 1986 May;83(10):3460–3464. doi: 10.1073/pnas.83.10.3460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Nawroth P. P., Stern D. M. Modulation of endothelial cell hemostatic properties by tumor necrosis factor. J Exp Med. 1986 Mar 1;163(3):740–745. doi: 10.1084/jem.163.3.740. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Nesheim M. E., Canfield W. M., Kisiel W., Mann K. G. Studies of the capacity of factor Xa to protect factor Va from inactivation by activated protein C. J Biol Chem. 1982 Feb 10;257(3):1443–1447. [PubMed] [Google Scholar]
  35. Nicolaes G. A., Tans G., Thomassen M. C., Hemker H. C., Pabinger I., Varadi K., Schwarz H. P., Rosing J. Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem. 1995 Sep 8;270(36):21158–21166. doi: 10.1074/jbc.270.36.21158. [DOI] [PubMed] [Google Scholar]
  36. Rosing J., Hoekema L., Nicolaes G. A., Thomassen M. C., Hemker H. C., Varadi K., Schwarz H. P., Tans G. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C. J Biol Chem. 1995 Nov 17;270(46):27852–27858. doi: 10.1074/jbc.270.46.27852. [DOI] [PubMed] [Google Scholar]
  37. Rosing J., Zwaal R. F., Tans G. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation. J Biol Chem. 1986 Mar 25;261(9):4224–4228. [PubMed] [Google Scholar]
  38. Scarpati E. M., Sadler J. E. Regulation of endothelial cell coagulant properties. Modulation of tissue factor, plasminogen activator inhibitors, and thrombomodulin by phorbol 12-myristate 13-acetate and tumor necrosis factor. J Biol Chem. 1989 Dec 5;264(34):20705–20713. [PubMed] [Google Scholar]
  39. Solymoss S., Tucker M. M., Tracy P. B. Kinetics of inactivation of membrane-bound factor Va by activated protein C. Protein S modulates factor Xa protection. J Biol Chem. 1988 Oct 15;263(29):14884–14890. [PubMed] [Google Scholar]
  40. Tans G., Nicolaes G. A., Thomassen M. C., Hemker H. C., van Zonneveld A. J., Pannekoek H., Rosing J. Activation of human factor V by meizothrombin. J Biol Chem. 1994 Jun 10;269(23):15969–15972. [PubMed] [Google Scholar]
  41. Tans G., Rosing J., Thomassen M. C., Heeb M. J., Zwaal R. F., Griffin J. H. Comparison of anticoagulant and procoagulant activities of stimulated platelets and platelet-derived microparticles. Blood. 1991 Jun 15;77(12):2641–2648. [PubMed] [Google Scholar]
  42. Taylor F. B., Jr, Chang A. C., Peer G. T., Mather T., Blick K., Catlett R., Lockhart M. S., Esmon C. T. DEGR-factor Xa blocks disseminated intravascular coagulation initiated by Escherichia coli without preventing shock or organ damage. Blood. 1991 Jul 15;78(2):364–368. [PubMed] [Google Scholar]
  43. Taylor F. B., Jr, Chang A., Esmon C. T., D'Angelo A., Vigano-D'Angelo S., Blick K. E. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon. J Clin Invest. 1987 Mar;79(3):918–925. doi: 10.1172/JCI112902. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Taylor F., Chang A., Ferrell G., Mather T., Catlett R., Blick K., Esmon C. T. C4b-binding protein exacerbates the host response to Escherichia coli. Blood. 1991 Jul 15;78(2):357–363. [PubMed] [Google Scholar]
  45. Tijburg P. N., van Heerde W. L., Leenhouts H. M., Hessing M., Bouma B. N., de Groot P. G. Formation of meizothrombin as intermediate in factor Xa-catalyzed prothrombin activation on endothelial cells. The influence of thrombin on the reaction mechanism. J Biol Chem. 1991 Feb 25;266(6):4017–4022. [PubMed] [Google Scholar]
  46. Vehar G. A., Davie E. W. Preparation and properties of bovine factor VIII (antihemophilic factor). Biochemistry. 1980 Feb 5;19(3):401–410. doi: 10.1021/bi00544a001. [DOI] [PubMed] [Google Scholar]
  47. Walker F. J. Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation. J Biol Chem. 1981 Nov 10;256(21):11128–11131. [PubMed] [Google Scholar]
  48. Walker F. J., Sexton P. W., Esmon C. T. The inhibition of blood coagulation by activated Protein C through the selective inactivation of activated Factor V. Biochim Biophys Acta. 1979 Dec 7;571(2):333–342. doi: 10.1016/0005-2744(79)90103-7. [DOI] [PubMed] [Google Scholar]
  49. Warr T. A., Rao L. V., Rapaport S. I. Disseminated intravascular coagulation in rabbits induced by administration of endotoxin or tissue factor: effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity. Blood. 1990 Apr 1;75(7):1481–1489. [PubMed] [Google Scholar]
  50. Willems C., Astaldi G. C., De Groot P. G., Janssen M. C., Gonsalvez M. D., Zeijlemaker W. P., Van Mourik J. A., Van Aken W. G. Media conditioned by cultured human vascular endothelial cells inhibit the growth of vascular smooth muscle cells. Exp Cell Res. 1982 May;139(1):191–197. doi: 10.1016/0014-4827(82)90332-9. [DOI] [PubMed] [Google Scholar]
  51. Wu Q., Tsiang M., Lentz S. R., Sadler J. E. Ligand specificity of human thrombomodulin. Equilibrium binding of human thrombin, meizothrombin, and factor Xa to recombinant thrombomodulin. J Biol Chem. 1992 Apr 5;267(10):7083–7088. [PubMed] [Google Scholar]
  52. van 't Veer C., Hackeng T. M., Delahaye C., Sixma J. J., Bouma B. N. Activated factor X and thrombin formation triggered by tissue factor on endothelial cell matrix in a flow model: effect of the tissue factor pathway inhibitor. Blood. 1994 Aug 15;84(4):1132–1142. [PubMed] [Google Scholar]
  53. van't Veer C., Hackeng T. M., Biesbroeck D., Sixma J. J., Bouma B. N. Increased prothrombin activation in protein S-deficient plasma under flow conditions on endothelial cell matrix: an independent anticoagulant function of protein S in plasma. Blood. 1995 Apr 1;85(7):1815–1821. [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES